Report Code: 12416 | Available Format: PDF | Pages: 210
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by technology
1.4.2. Market size breakdown, by modality
1.4.3. Market size breakdown, by application
1.4.4. Market size breakdown, by end user
1.4.5. Market size breakdown, by region
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Exeutive Summary
Chapter 4. Definitions
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Global Market
6.1. Overview
6.2. Market Revenue, by Technology (2019–2030)
6.3. Market Revenue, by Modality (2019–2030)
6.4. Market Revenue, by Application (2019–2030)
6.5. Market Revenue, by End User (2019–2030)
6.6. Market Revenue, by Region (2019–2030)
Chapter 7. North America Market
7.1. Overview
7.2. Market Revenue, by Technology (2019–2030)
7.3. Market Revenue, by Modality (2019–2030)
7.4. Market Revenue, by Application (2019–2030)
7.5. Market Revenue, by End User (2019–2030)
7.6. Market Revenue, by Country (2019–2030)
Chapter 8. Europe Market
8.1. Overview
8.2. Market Revenue, by Technology (2019–2030)
8.3. Market Revenue, by Modality (2019–2030)
8.4. Market Revenue, by Application (2019–2030)
8.5. Market Revenue, by End User (2019–2030)
8.6. Market Revenue, by Country (2019–2030)
Chapter 9. APAC Market
9.1. Overview
9.2. Market Revenue, by Technology (2019–2030)
9.3. Market Revenue, by Modality (2019–2030)
9.4. Market Revenue, by Application (2019–2030)
9.5. Market Revenue, by End User (2019–2030)
9.6. Market Revenue, by Country (2019–2030)
Chapter 10. LATAM Market
10.1. Overview
10.2. Market Revenue, by Technology (2019–2030)
10.3. Market Revenue, by Modality (2019–2030)
10.4. Market Revenue, by Application (2019–2030)
10.5. Market Revenue, by End User (2019–2030)
10.6. Market Revenue, by Country (2019–2030)
Chapter 11. MEA Market
11.1. Overview
11.2. Market Revenue, by Technology (2019–2030)
11.3. Market Revenue, by Modality (2019–2030)
11.4. Market Revenue, by Application (2019–2030)
11.5. Market Revenue, by End User (2019–2030)
11.6. Market Revenue, by Country (2019–2030)
Chapter 12. Competitive Landscape
12.1. Market Share of Key Players
12.2. List of Market Players and their Offerings
12.3. Competitive Benchmarking of Key Players
12.4. Recent Strategic Developments
Chapter 13. Company Profiles
13.1. Agfa Gevaert N.V.
13.1.1. Business overview
13.1.2. Product and service offerings
13.1.3. Key financial summary
13.2. Siemens Healthineers
13.2.1. Business overview
13.2.2. Product and service offerings
13.2.3. Key financial summary
13.3. EchoNous Inc.
13.3.1. Business overview
13.3.2. Product and service offerings
13.3.3. Key financial summary
13.4. General Electric Company
13.4.1. Business overview
13.4.2. Product and service offerings
13.4.3. Key financial summary
13.5. Company 5
13.5.1. Business overview
13.5.2. Product and service offerings
13.5.3. Key financial summary
13.6. Company 6
13.6.1. Business overview
13.6.2. Product and service offerings
13.6.3. Key financial summary
13.7. Company 7
13.7.1. Business overview
13.7.2. Product and service offerings
13.7.3. Key financial summary
13.8. Company 8
13.8.1. Business overview
13.8.2. Product and service offerings
13.8.3. Key financial summary
13.9. Company 9
13.9.1. Business overview
13.9.2. Product and service offerings
13.9.3. Key financial summary
13.10. Company 10
13.10.1. Business overview
13.10.2. Product and service offerings
13.10.3. Key financial summary
13.11. Company 11
13.11.1. Business overview
13.11.2. Product and service offerings
13.11.3. Key financial summary
13.12. Company 12
13.12.1. Business overview
13.12.2. Product and service offerings
13.12.3. Key financial summary
13.13. Company 13
13.13.1. Business overview
13.13.2. Product and service offerings
13.13.3. Key financial summary
13.14. Company 14
13.14.1. Business overview
13.14.2. Product and service offerings
13.14.3. Key financial summary
13.15. Company 15
13.15.1. Business overview
13.15.2. Product and service offerings
13.15.3. Key financial summary
Chapter 14. Appendix
14.1. Abbreviations
14.2. Sources and References
14.3. Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 5 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 6 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 7 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 8 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 9 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 10 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 11 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 12 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 13 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 14 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 15 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 16 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY REGION, $M (2017–2022)
TABLE 17 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY REGION, $M (2023–2026)
TABLE 18 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY REGION, $M (2027–2030)
TABLE 19 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 20 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 21 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 22 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 23 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 24 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 25 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 26 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 27 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 28 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 29 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 30 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 31 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2017–2022)
TABLE 32 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2023–2026)
TABLE 33 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 34 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 35 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 36 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 37 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 38 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 39 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 40 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 41 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 42 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 43 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 44 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 45 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 46 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2017–2022)
TABLE 47 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2023–2026)
TABLE 48 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 49 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 50 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 51 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 52 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 53 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 54 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 55 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 56 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 57 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 58 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 59 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 60 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 61 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2017–2022)
TABLE 62 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2023–2026)
TABLE 63 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 64 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 65 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 66 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 67 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 68 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 69 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 70 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 71 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 72 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 73 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 74 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 75 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 76 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2017–2022)
TABLE 77 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2023–2026)
TABLE 78 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 79 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2017–2022)
TABLE 80 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2023–2026)
TABLE 81 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2027–2030)
TABLE 82 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2017–2022)
TABLE 83 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2023–2026)
TABLE 84 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2027–2030)
TABLE 85 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2017–2022)
TABLE 86 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2023–2026)
TABLE 87 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2027–2030)
TABLE 88 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2017–2022)
TABLE 89 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2023–2026)
TABLE 90 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2027–2030)
TABLE 91 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2017–2022)
TABLE 92 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2023–2026)
TABLE 93 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2027–2030)
TABLE 94 COMPANY 1 – AT A GLANCE
TABLE 95 COMPANY 1 – KEY FINANCIAL SUMMARY
TABLE 96 COMPANY 2 – AT A GLANCE
TABLE 97 COMPANY 2 – KEY FINANCIAL SUMMARY
TABLE 98 COMPANY 3 – AT A GLANCE
TABLE 99 COMPANY 3 – KEY FINANCIAL SUMMARY
TABLE 100 COMPANY 4 – AT A GLANCE
TABLE 101 COMPANY 4 – KEY FINANCIAL SUMMARY
TABLE 102 COMPANY 5 – AT A GLANCE
TABLE 103 COMPANY 5 – KEY FINANCIAL SUMMARY
TABLE 104 COMPANY 6 – AT A GLANCE
TABLE 105 COMPANY 6 – KEY FINANCIAL SUMMARY
TABLE 106 COMPANY 7 – AT A GLANCE
TABLE 107 COMPANY 7 – KEY FINANCIAL SUMMARY
TABLE 108 COMPANY 8 – AT A GLANCE
TABLE 109 COMPANY 8 – KEY FINANCIAL SUMMARY
TABLE 110 COMPANY 9 – AT A GLANCE
TABLE 111 COMPANY 9 – KEY FINANCIAL SUMMARY
TABLE 112 COMPANY 10 – AT A GLANCE
TABLE 113 COMPANY 10 – KEY FINANCIAL SUMMARY
TABLE 114 COMPANY 11 – AT A GLANCE
TABLE 115 COMPANY 11 – KEY FINANCIAL SUMMARY
TABLE 116 COMPANY 12 – AT A GLANCE
TABLE 117 COMPANY 12 – KEY FINANCIAL SUMMARY
TABLE 118 COMPANY 13 – AT A GLANCE
TABLE 119 COMPANY 13 – KEY FINANCIAL SUMMARY
TABLE 120 COMPANY 14 – AT A GLANCE
TABLE 121 COMPANY 14 – KEY FINANCIAL SUMMARY
TABLE 122 COMPANY 15 – AT A GLANCE
TABLE 123 COMPANY 15 – KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 CURRENCY CONVERSION RATES FOR USD (2023)
FIG 8 GLOBAL AI-BASED MEDICAL IMAGING MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 15 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 16 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 17 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 18 GLOBAL AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 19 MAJOR WORLDWIDE MARKETS FOR AI-BASED MEDICAL IMAGING SOLUTIONS, $M
FIG 20 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 21 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 22 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 23 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 24 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 25 NORTH AMERICA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 26 EUROPE AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 27 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 28 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 29 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 30 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 31 EUROPE AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 32 APAC AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 33 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 34 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 35 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 36 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 37 APAC AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 38 LATAM AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 39 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 40 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 41 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 42 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 43 LATAM AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 44 MEA AI-BASED MEDICAL IMAGING MARKET SNAPSHOT
FIG 45 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY TECHNOLOGY, $M (2019–2030)
FIG 46 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY MODALITY, $M (2019–2030)
FIG 47 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY APPLICATION, $M (2019–2030)
FIG 48 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY END USER, $M (2019–2030)
FIG 49 MEA AI-BASED MEDICAL IMAGING MARKET REVENUE, BY COUNTRY, $M (2019–2030)
FIG 50 COMPANY 1 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 51 COMPANY 2 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 52 COMPANY 3 – REVENUE SPLIT BY SOURCE AND GEOGRAPHY (2023)
FIG 53 COMPANY 4 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 54 COMPANY 5 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 55 COMPANY 6 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 56 COMPANY 7 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 57 COMPANY 8 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 58 COMPANY 9 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 59 COMPANY 10 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 60 COMPANY 11 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 61 COMPANY 12 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 62 COMPANY 13 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 63 COMPANY 14 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 64 COMPANY 15 – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws